Overview

Pilot Study of Growth Hormon to Treat SMA Typ II and III

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Growth hormon can increase strength in spinal muscular atrophy type II and III.
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital Freiburg
Collaborator:
Novo Nordisk A/S